Hinge Health, Inc. (HNGE)
Hinge Health will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Company Description

Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.

We have designed our platform to address a broad spectrum of MSK (musculoskeletal system) care—from acute injury, to chronic pain, to post-surgical rehabilitation.

Members receive personalized and largely automated MSK care through our AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device, all designed and monitored by our AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches.

Our platform can improve pain and function and reduce the need for surgeries, all while driving health equity by allowing members to engage in their exercise therapy sessions from anywhere and embrace movement as a way of life.

To address healthcare reimbursement constraints, we developed novel billing methods for our innovative technology by both directly selling to employers while also partnering with health plans, pharmacy benefit managers, third-party administrators, and other ecosystem entities to efficiently provide our platform to clients and members.

Hinge Health, Inc.
Country United States
Founded 2012
Industry Medical Devices
Sector Healthcare
Employees 1,437
CEO Daniel Perez

Contact Details

Address:
455 Market Street, Suite 700
San Francisco, CA 94105
United States
Phone (415) 726-2206
Website hingehealth.com

Stock Details

Ticker Symbol HNGE
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001673743
Employer ID 81-1884841
SIC Code 7374

Key Executives

Name Position
Daniel Perez Chief Executive Officer, Co-Founder, and Director
James Budge Chief Financial Officer
Jim Pursley President
Gabriel Mecklenburg Executive Chairman, Co-Founder, and Director
Kristina Leslie Director
Elliott Robinson Director
Teddie Wardi Director

Latest SEC Filings

Date Type Title
Mar 10, 2025 S-1 General form for registration of securities under the Securities Act of 1933
Feb 14, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Jan 17, 2025 DRS/A [Amend] [Cover] Draft Registration Statement
Nov 15, 2024 DRS [Cover] Draft Registration Statement
Dec 28, 2023 D Notice of Exempt Offering of Securities
Dec 21, 2023 D Notice of Exempt Offering of Securities
Apr 1, 2021 D Notice of Exempt Offering of Securities
Jul 1, 2020 D Notice of Exempt Offering of Securities
Jul 1, 2020 D Notice of Exempt Offering of Securities
Jun 6, 2019 D Notice of Exempt Offering of Securities